Health officials have concerns as people nationwide participate in mass gatherings to protest the death of George Floyd; Trump cuts US ties with WHO over handling of coronavirus disease 2019 (COVID-19); former FDA commisioner Scott Gottlieb, MD, says addressing racial inequities in COVID-19 transmission and higher death rates could halt the pandemic.
As protests involving the death of George Floyd continue to grow nationwide, the gathering of mass crowds and responses by law enforcement may threaten efforts by health officials to track and contain the spread of the coronavirus disease 2019 (COVID-19), reported The Associated Press. Contact tracing, which requires infected individuals to remember everyone in contact they have been in with within the past several days, could prove impossible with mass gatherings. In addition, public mistrust of government and police could complicate efforts. However, William Schaffner, MD, an infectious disease expert at Vanderbilt University, notes that as the protests were outside and since many of the people involved wore masks, much of the contact may be less hazardous.
President Donald Trump announced last Friday that the United States will cut ties with the World Health Organization (WHO), citing its handling of the COVID-19 pandemic, according to Reuters. The move follows rising tensions between the Trump administration and China, with Trump saying Chinese officials failed to report the virus as obligated to WHO. The US initially joined WHO in 1948, and currently owes more than $200 million in assessed contributions.
Former FDA Commissioner Scott Gottlieb, MD, noted that addressing underlying problems of racial inequity in the US could halt the COVID-19 pandemic, according to The Hill. Racial inequities amid the pandemic, which has been shown to impact communities of color at disproportionate rates, may be addressed at 2 levels, he said—why there are higher rates of COVID-19, and subsequently, how this leads to higher death rates among black Americans.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More